210 related articles for article (PubMed ID: 20201282)
1. Synthesis and antituberculosis action of some new pyruvic acid derivatives.
Ungureanu M; Diculencu D; Archip C
Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):860-4. PubMed ID: 20201282
[TBL] [Abstract][Full Text] [Related]
2. Antituberculosis agents, I: Synthesis and antituberculosis activity of 2-aryl-1,3,4-thiadiazole derivatives.
Foroumadi A; Mirzaei M; Shafiee A
Pharmazie; 2001 Aug; 56(8):610-2. PubMed ID: 11534334
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies.
Chitra S; Paul N; Muthusubramanian S; Manisankar P; Yogeeswari P; Sriram D
Eur J Med Chem; 2011 Oct; 46(10):4897-903. PubMed ID: 21855182
[TBL] [Abstract][Full Text] [Related]
4. Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents.
Alegaon SG; Alagawadi KR; Sonkusare PV; Chaudhary SM; Dadwe DH; Shah AS
Bioorg Med Chem Lett; 2012 Mar; 22(5):1917-21. PubMed ID: 22325950
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of antitubercular activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives.
Kolavi G; Hegde V; Khazi Ia; Gadad P
Bioorg Med Chem; 2006 May; 14(9):3069-80. PubMed ID: 16406644
[TBL] [Abstract][Full Text] [Related]
6. Researches concerning the synthesis and antituberculosis action of some new sulphacetamide derivatives.
Ungureanu M; Diculencu D; Stirbu CA
Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):456-9. PubMed ID: 17802961
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
Menendez C; Gau S; Lherbet C; Rodriguez F; Inard C; Pasca MR; Baltas M
Eur J Med Chem; 2011 Nov; 46(11):5524-31. PubMed ID: 21944473
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel [1,2]-diamines with antituberculosis activity.
Meng Q; Luo H; Chen Y; Wang T; Yao Q
Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis of 1,3,4-thiadiazole derivatives with potential tuberculostatic action].
Santus M
Acta Pol Pharm; 1988; 45(3):219-24. PubMed ID: 3149139
[No Abstract] [Full Text] [Related]
10. Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis.
Shanmugavelan P; Nagarajan S; Sathishkumar M; Ponnuswamy A; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2011 Dec; 21(24):7273-6. PubMed ID: 22061642
[TBL] [Abstract][Full Text] [Related]
11. 1,3,4-thiadiazole derivatives. Synthesis, structure elucidation, and structure-antituberculosis activity relationship investigation.
Oruç EE; Rollas S; Kandemirli F; Shvets N; Dimoglo AS
J Med Chem; 2004 Dec; 47(27):6760-7. PubMed ID: 15615525
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and investigation of tuberculosis inhibition activities of some 1,2,3-triazole derivatives.
Dabak K; Sezer O; Akar A; Anaç O
Eur J Med Chem; 2003 Feb; 38(2):215-8. PubMed ID: 12620665
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety.
Güzeldemirci NU; Küçükbasmaci O
Eur J Med Chem; 2010 Jan; 45(1):63-8. PubMed ID: 19939519
[TBL] [Abstract][Full Text] [Related]
14. Chemical synthesis and biological evaluation of triazole derivatives as inhibitors of InhA and antituberculosis agents.
Menendez C; Chollet A; Rodriguez F; Inard C; Pasca MR; Lherbet C; Baltas M
Eur J Med Chem; 2012 Jun; 52():275-83. PubMed ID: 22483635
[TBL] [Abstract][Full Text] [Related]
15. Application of Huisgen (3+2) cycloaddition reaction: synthesis of 1-(2,3-dihydrobenzofuran-2-yl-methyl [1,2,3]-triazoles and their antitubercular evaluations.
Tripathi RP; Yadav AK; Ajay A; Bisht SS; Chaturvedi V; Sinha SK
Eur J Med Chem; 2010 Jan; 45(1):142-8. PubMed ID: 19846238
[TBL] [Abstract][Full Text] [Related]
16. Linked pyridinyl-thiadiazoles: Design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis.
Mahajan NS; Dhawale SC
Eur J Med Chem; 2015 Sep; 102():243-8. PubMed ID: 26280920
[TBL] [Abstract][Full Text] [Related]
17. Clubbed triazoles: a novel approach to antitubercular drugs.
Shiradkar M; Suresh Kumar GV; Dasari V; Tatikonda S; Akula KC; Shah R
Eur J Med Chem; 2007 Jun; 42(6):807-16. PubMed ID: 17239490
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
Costa MS; Boechat N; Rangel EA; da Silva Fde C; de Souza AM; Rodrigues CR; Castro HC; Junior IN; Lourenço MC; Wardell SM; Ferreira VF
Bioorg Med Chem; 2006 Dec; 14(24):8644-53. PubMed ID: 16949290
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D; Peethambar SK; Achur R; Kumar HS
Eur J Med Chem; 2015 May; 95():49-63. PubMed ID: 25794789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
